| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CTI BioPharma Corp (NASDAQ: CTIC)
CTIC Technical Analysis
5
| As on 23rd Jun 2023 CTIC STOCK Price closed @ 9.09 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.88 & Strong Buy for SHORT-TERM with Stoploss of 2.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CTICSTOCK Price
| Open | 9.10 | Change | Price | % |
| High | 9.10 | 1 Day | 0.00 | 0.00 |
| Low | 9.09 | 1 Week | 0.01 | 0.11 |
| Close | 9.09 | 1 Month | 4.27 | 88.59 |
| Volume | 11217834 | 1 Year | 6.61 | 266.53 |
| 52 Week High 9.10 | 52 Week Low 1.90 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| LMDX | 0.02 | 0.00% |
| LCID | 3.20 | 3.23% |
| AVGR | 1.45 | 126.56% |
| NVDA | 140.22 | 0.39% |
| AKTS | 0.04 | 0.00% |
| TNXP | 0.39 | -2.50% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CTIC Daily Charts |
CTIC Intraday Charts |
Whats New @ Bazaartrend |
CTIC Free Analysis |
|
|
CTIC Important Levels Intraday
| RESISTANCE | 9.11 |
| RESISTANCE | 9.10 |
| RESISTANCE | 9.10 |
| RESISTANCE | 9.10 |
| SUPPORT | 9.08 |
| SUPPORT | 9.08 |
| SUPPORT | 9.08 |
| SUPPORT | 9.07 |
CTIC Forecast December 2024
| 4th UP Forecast | 14.97 |
| 3rd UP Forecast | 13.08 |
| 2nd UP Forecast | 11.92 |
| 1st UP Forecast | 10.75 |
| 1st DOWN Forecast | 7.43 |
| 2nd DOWN Forecast | 6.26 |
| 3rd DOWN Forecast | 5.1 |
| 4th DOWN Forecast | 3.21 |
CTIC Weekly Forecast
| 4th UP Forecast | 9.80 |
| 3rd UP Forecast | 9.57 |
| 2nd UP Forecast | 9.43 |
| 1st UP Forecast | 9.29 |
| 1st DOWN Forecast | 8.89 |
| 2nd DOWN Forecast | 8.75 |
| 3rd DOWN Forecast | 8.61 |
| 4th DOWN Forecast | 8.38 |
CTIC Forecast2024
| 4th UP Forecast | 23.12 |
| 3rd UP Forecast | 18.62 |
| 2nd UP Forecast | 15.84 |
| 1st UP Forecast | 13.06 |
| 1st DOWN Forecast | 5.12 |
| 2nd DOWN Forecast | 2.34 |
| 3rd DOWN Forecast | -0.44 |
| 4th DOWN Forecast | -4.94 |
CTI BioPharma Corp ( NASDAQ USA Symbol : CTIC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CTIC Business Profile
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington. Address: 3101 Western Avenue, Seattle, WA, United States, 98121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service